MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Skin Cancer, Melanoma
Kinnate Biopharma Inc (NASDAQ: KNTE)
Finance & Acquisition: Kinnate Biopharma
Parents
Kinnate Biopharma Inc (NASDAQ: KNTE)
Children
2020: Investors in Kinnate’s latest round include RA Capital, Viking Global Investors, Venrock Healthcare Capital Partners, Fidelity Management & Research Company, Janus Henderson Investors, Citadel’s Surveyor Capital, the Tavistock Group’s Boxer Capital, Logos Capital, SVB Leerink, Foresite Capital, OrbiMed, Nextech Invest, and Vida Ventures
2020: IPO Update: Kinnate Biopharma Proposes Terms For $170 Million IPO
2020: Kinnate Biopharma Seeks IPO For Kinase Inhibitor Approach
2020: Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies
2023: Kinnate lays off 70% of employees, shaves pipeline to focus on CDK4 and pan-RAF inhibitor
2024: XOMA Agrees to Acquire Kinnate Biopharma
Jumps
Key People: Kinnate Biopharma
Organization & Developments: Kinnate Biopharma